Navidea Biopharmaceuticals’ Lymphoseek® (technetium Tc 99m tilmanocept) Injection Demonstrates Preferential Accumulation in Tumor-Positive Sentinel Lymph Nodes in Post-Hoc Analysis Jun 11, 2014
Navidea Biopharmaceuticals Announces Positive Lymphoseek® (technetium Tc 99m tilmanocept) Injection Results on Injection Timing and Surgery Across Multiple Solid Tumor Types Jun 10, 2014
Navidea Announces Data Demonstrating Potential of Manocept™ Platform to Diagnose Rheumatoid Arthritis and Kaposi’s Sarcoma Jun 10, 2014
Navidea Biopharmaceuticals to Present at the Jefferies 2014 Global Healthcare Conference May 29, 2014
Navidea Announces Eleven Scientific Presentations of Results from Lymphoseek® and Manocept™ Studies at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting May 20, 2014
Navidea Biopharmaceuticals to Announce First Quarter 2014 Financial Results on May 7, 2014 Apr 29, 2014
Navidea Announces Presentation of Study Findings of Manocept™ Platform Imaging Agent in Kaposi Sarcoma at AACR Annual Meeting Apr 10, 2014
